New Delhi, July 12 -- Bengaluru's Anthem Biosciences, a contract research, development, and manufacturing organization, secured Rs.1,016.02 crore from 60 institutional investors through its anchor book on July 11.

This fundraising event occurred just a day prior to the IPO launch, which is set to open on July 14. The public offering will conclude on July 16.

In its announcement to the exchanges on Friday, Anthem Biosciences disclosed that it has allocated 1.78 crore equity shares to anchor investors at Rs.570 per share. The price range has been established between Rs.540 and Rs.570, with an indicative market capitalization of Rs.31,800 crore.

JM Financial Ltd, Citigroup Global Markets India, J P Morgan India, and Nomura Financial Advis...